Spots Global Cancer Trial Database for lymphocyte
Every month we try and update this database with for lymphocyte cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) | NCT00519090 | Myelogenous Leu... | Imatinib Nilotinib (AMN1... | 18 Years - | Novartis | |
| E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers | NCT05686226 | Cervical Cancer Throat Cancer Oropharynx Canc... Anal Cancer Vulva Cancer Vaginal Cancer Penile Cancer Metastatic Canc... HPV-Related Mal... HPV-Related Car... HPV-Related Cer... HPV-Related Squ... HPV-Related Ade... HPV Positive Or... HPV-Associated ... HPV-Related Ade... HPV-Related End... HPV-Related Ana... HPV-Related Pen... HPV-Related Vul... HPV Positive Re... | E7 TCR-T cells | 18 Years - | Rutgers, The State University of New Jersey | |
| PH2 Trial in Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL) With a Combination of Bendamustine & Ofatumumab | NCT01131247 | Chronic Lymphoc... | ofatumumab + be... | 18 Years - | Nevada Cancer Institute | |
| Optimization of Radiation Protection Through Genomic Analyses | NCT06253338 | DNA Cancer Radiation | genomic alterat... | 18 Years - | University Hospital, Essen | |
| Preoperative Administration of Oral Carbohydrate Drink, Neutrophil/Lymphocyte Ratio and Postoperative Complications | NCT05301985 | Neutrophil Lymphocyte Postoperative C... | preoperative nu... | 18 Years - 70 Years | Cantonal Hospital Zenica | |
| Nilotinib vs Imatinib in Adult Patients With Philadelphia (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) | NCT00519090 | Myelogenous Leu... | Imatinib Nilotinib (AMN1... | 18 Years - | Novartis | |
| Probiotics In Colorectal Cancer Patients | NCT00936572 | Colorectal Canc... | Probiotics (La1... probiotics (La1... placebo | 18 Years - 80 Years | University of Milano Bicocca | |
| Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) | NCT00593944 | Chronic Lymphoc... | MDX-1342 | 18 Years - | Bristol-Myers Squibb | |
| Optimization of Radiation Protection Through Genomic Analyses | NCT06253338 | DNA Cancer Radiation | genomic alterat... | 18 Years - | University Hospital, Essen | |
| Probiotics In Colorectal Cancer Patients | NCT00936572 | Colorectal Canc... | Probiotics (La1... probiotics (La1... placebo | 18 Years - 80 Years | University of Milano Bicocca | |
| Probiotics In Colorectal Cancer Patients | NCT00936572 | Colorectal Canc... | Probiotics (La1... probiotics (La1... placebo | 18 Years - 80 Years | University of Milano Bicocca | |
| The Evaluation of Curative Effect on Treatment of Tumor Above Thalidomide Combined With Megestrol | NCT03777930 | Cancer, Therapy... | Chemotherapy dr... thalidomide and... optimal support... thalidomide and... | 18 Years - | Shenzhen Fifth People's Hospital | |
| Study of MDX-1342 in Patients With Chronic Lymphocytic Leukemia (CLL) | NCT00593944 | Chronic Lymphoc... | MDX-1342 | 18 Years - | Bristol-Myers Squibb | |
| Lymphocytes Subpopulation in Cancer Patients | NCT02516371 | Cancer | lymphocyte | 20 Years - 80 Years | The Catholic University of Korea | |
| Optimization of Radiation Protection Through Genomic Analyses | NCT06253338 | DNA Cancer Radiation | genomic alterat... | 18 Years - | University Hospital, Essen | |
| A Study of Imatinib Versus Nilotinib in Adult Patients With Newly Diagnosed Philadelphia Chromosome Positive (Ph+) Chronic Myelogenous Leukemia in Chronic Phase (CML-CP) | NCT00471497 | Myelogenous Leu... | nilotinib imatinib | 18 Years - | Novartis |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
